VSee Health, Inc. Stock Price, News & Analysis

VSee Health (NASDAQ:VSEE) announced it is appealing a NASDAQ Staff Determination to delist its common stock from the Nasdaq Capital Market. The delisting notice was received on August 5th, 2025, citing non-compliance with filing requirements for the 2024 Annual Report and Q1 2025 Quarterly Report.

The company has requested a hearing before the Nasdaq Listing Qualifications Panel, which automatically stays the delisting for 15 days. VSee Health plans to request an extended stay pending the hearing. If the appeal is unsuccessful, the company's stock could move to trading on the OTC Bulletin Board.

VSee Health (NASDAQ:VSEE) has launched its new AI Doctor Notes solution, partnering with Tele911, the largest national telemedicine emergency room diversion service. The AI-powered solution has achieved a remarkable 93% reduction in physician documentation time, cutting charting time from 15 minutes to under 1 minute per visit.

The system automatically generates structured SOAP notes with ICD codes in two clicks, integrating seamlessly with Tele911's virtual emergency care workflow. The solution is available both as an integrated feature in VSee's digital health platform and as a standalone product compatible with any EHR system.

VSee Health (NASDAQ:VSEE) has launched its new AI Doctor Notes solution, partnering with Tele911, the largest national telemedicine emergency room diversion service. The AI-powered system has demonstrated a remarkable 93% reduction in documentation time, cutting physician charting time from 15 minutes to under 1 minute per visit.

The solution automatically transcribes visits and generates structured SOAP notes with ICD codes in two clicks. It's available both as an integrated feature in VSee's digital health platform and as a standalone solution compatible with any EHR. The integration aims to enhance clinical efficiency and allow physicians to focus more on patient care rather than administrative tasks.

VSee Health has been selected to support a NIH-funded Phase 3 clinical trial studying stroke recovery telerehabilitation at UCLA. The trial involves 29 hospitals and 202 patients, evaluating a 6-week gamified home-based telerehab program to improve arm functionality in stroke survivors. The study aims to reduce costs related to transportation, caregiver burdens, and hospital readmissions. VSee's HIPAA-compliant platform will facilitate secure delivery of interventions in the $328M global stroke rehab market. The trial, beginning Q3 2025, represents a significant milestone after twelve years of development and builds on VSee's involvement in previous Phase 1 and 2 studies. Success could lead to Medicare and private payer reimbursement while opening opportunities for telerehabilitation in other neurological conditions.

VSee Health (NASDAQ: VSEE) has received a notice from Nasdaq on May 23, 2025, regarding non-compliance with listing rule 5250(c)(1) due to delayed filing of its Q1 2025 Form 10-Q and FY2024 Form 10-K. The company has until June 24, 2025, to submit a compliance plan. If Nasdaq accepts the plan, VSee may receive up to 180 days (until October 13, 2025) to regain compliance. The notice does not immediately affect VSee's stock or warrant listing on the Nasdaq Capital Market. The company has stated its intention to take necessary steps to file the required documents and regain compliance as soon as possible.

VSee Health (NASDAQ: VSEE) has launched Project MAMA (Mom's AI for Maternity Aid), a telehealth initiative aimed at reducing maternal mortality rates in rural Philippines. The project, implemented in Zamboanga Sibugay, combines AI-powered technology with remote healthcare delivery.

In collaboration with Stanford University and Ateneo de Zamboanga University specialists, the platform features AI chatbots supporting local languages, portable diagnostic devices including ultrasounds, and electronic health records. The system becomes operational within four days of deployment, enabling remote OB-GYN consultations for previously underserved communities.

Dr. Milton Chen, co-CEO, highlighted the company's plans to expand AI capabilities for analyzing patient data to detect early maternal mortality risks. The initiative represents VSee's strategic focus on expanding accessible healthcare through AI-enhanced telehealth solutions globally.

VSee Health (NASDAQ: VSEE) has received a notice from Nasdaq on April 25, 2025, regarding its failure to file the Annual Report on Form 10-K for the year ended December 31, 2024. The company is now non-compliant with Nasdaq's listing rule 5250(c)(1), which requires timely filing of periodic financial reports. While this notice does not immediately affect VSee's stock listing or trading status, the company has until June 24, 2025 to submit a compliance plan to Nasdaq. If accepted, Nasdaq may extend the compliance deadline to October 13, 2025. VSee Health has stated its intention to take necessary steps to file the Form 10-K and regain compliance as soon as possible.

VSee Health (NASDAQ: VSEE) has unveiled a new Telenursing Robotics solution, an AI-driven platform designed to automate routine nursing tasks in hospitals. The solution targets the $787 billion digital healthcare market and aims to reduce nursing-related expenses by 3-5%, addressing a major cost challenge as nursing represents approximately 60% of hospital operating budgets.

The company is initiating clinical pilot programs with select hospital partners, supported by research to quantify cost savings and workflow improvements. According to Dr. Imo Aisiku, Co-CEO, the platform is designed to be scalable nationally while improving patient satisfaction and operational efficiency. The solution combines AI, telehealth, and remote monitoring capabilities to enhance care delivery and accessibility.

VSee Health (NASDAQ: VSEE) is transforming the $787 billion digital healthcare market with its AI-powered telehealth solutions. The company offers a modular, no-code/low-code platform enabling healthcare organizations to build customized solutions with seamless EHR integration.

Recent notable contracts include:

• A $444K county government contract for mental health services
• A $560K contract for a secure telehealth platform with a major oncology network
• A $2 million hospital contract for neurocritical care expansion
• A multi-year government contract valued at $6 million in its first year

Key partnerships include AbundaBox for health record management, Ava Robotics for telepresence robots, and LanguageLine Solutions for multilingual services. The company processes over 1.5 million HIPAA-compliant video encounters monthly and serves major clients including NASA, U.S. Department of Health and Human Services, McKesson, DaVita, and Qatar.